ivabradine has been researched along with Shock, Cardiogenic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baka, T; Luptak, I; Repova, K; Simko, F | 1 |
| Camporotondo, R; Colombo, CNJ; Dammassa, V; Klersy, C; Mojoli, F; Pellegrini, C; Tavazzi, G | 1 |
| Diez-Mata, J; Hernandez, I; Pascual, M; Ramirez-Carracedo, R; Sanmartin, M; Saura, M; Tesoro, L; Zamorano, JL; Zaragoza, C | 1 |
| Castejón, B; Pascual Izco, M; Piedras, MJ; Sanmartín, M; Zamorano, JL; Zaragoza, C | 1 |
| Al-Kindi, SG; Oliveira, GH; Orasanu, G | 1 |
| Akodad, M; Lim, P; Roubille, F | 1 |
| Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Martino, F; Pannarale, G; Pannitteri, G; Paravati, V; Tanzilli, G; Torromeo, C | 1 |
| Münzel, T; Post, F | 1 |
| Becker, M; Koch, KC; Lepper, W; Westenfeld, R; Zwicker, C | 1 |
1 review(s) available for ivabradine and Shock, Cardiogenic
| Article | Year |
|---|---|
[Ivabradine - a new therapeutic option for cardiogenic shock?].
Topics: Benzazepines; Humans; Ivabradine; Shock, Cardiogenic | 2009 |
1 trial(s) available for ivabradine and Shock, Cardiogenic
| Article | Year |
|---|---|
Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study.
Topics: Acute Disease; Adult; Aged; Benzazepines; Cardiovascular Agents; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Ventricular Function, Left | 2016 |
7 other study(ies) available for ivabradine and Shock, Cardiogenic
| Article | Year |
|---|---|
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective.
Topics: Benzazepines; COVID-19; COVID-19 Drug Treatment; Heart Rate; Humans; Ivabradine; Myocarditis; Shock, Cardiogenic | 2022 |
Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support.
Topics: Heart Rate; Hemodynamics; Humans; Ivabradine; Shock, Cardiogenic; Stroke Volume; Vasoconstrictor Agents | 2022 |
Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation.
Topics: Animals; Cardiotonic Agents; Extracellular Matrix; Heart; Heart Rate; Ivabradine; Shock, Cardiogenic; Swine | 2021 |
Effects of Ivabradine on Heart Rate and Hemodynamic Parameters in a Swine Model of Cardiogenic Shock.
Topics: Animals; Arterial Pressure; Benzazepines; Blood Pressure; Cardiac Output; Central Venous Pressure; Female; Heart Rate; Hemodynamics; Ivabradine; Myocardial Infarction; Pulmonary Artery; Pulmonary Wedge Pressure; Shock, Cardiogenic; Swine; Tidal Volume | 2017 |
Ivabradine in Management of Heart Failure: a Critical Appraisal.
Topics: Arrhythmias, Cardiac; Benzazepines; Cardiomyopathies; Cardiovascular Agents; Clinical Studies as Topic; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Ultrasonography | 2016 |
Does ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy.
Topics: Benzazepines; Dobutamine; Humans; Ivabradine; Shock, Cardiogenic | 2016 |
Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.
Topics: Adult; Benzazepines; Cardiomyopathies; Catheterization, Swan-Ganz; Diagnosis, Differential; Female; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Syncope; Tachycardia; Treatment Outcome | 2010 |